Logo image of GBT.PA

GUERBET (GBT.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:GBT - FR0000032526 - Common Stock

17.56 EUR
-0.46 (-2.55%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

4

Overall GBT gets a fundamental rating of 4 out of 10. We evaluated GBT against 64 industry peers in the Health Care Equipment & Supplies industry. While GBT seems to be doing ok healthwise, there are quite some concerns on its profitability. GBT has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

GBT had positive earnings in the past year.
GBT had a positive operating cash flow in the past year.
Of the past 5 years GBT 4 years were profitable.
Each year in the past 5 years GBT had a positive operating cash flow.
GBT.PA Yearly Net Income VS EBIT VS OCF VS FCFGBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

GBT has a Return On Assets of 0.76%. This is in the lower half of the industry: GBT underperforms 63.08% of its industry peers.
GBT has a Return On Equity of 2.06%. This is in the lower half of the industry: GBT underperforms 63.08% of its industry peers.
GBT has a Return On Invested Capital of 3.17%. This is in the lower half of the industry: GBT underperforms 66.15% of its industry peers.
GBT had an Average Return On Invested Capital over the past 3 years of 4.08%. This is significantly below the industry average of 9.33%.
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROIC 3.17%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
GBT.PA Yearly ROA, ROE, ROICGBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

GBT's Profit Margin of 0.96% is on the low side compared to the rest of the industry. GBT is outperformed by 63.08% of its industry peers.
GBT's Profit Margin has declined in the last couple of years.
GBT has a worse Operating Margin (4.23%) than 66.15% of its industry peers.
In the last couple of years the Operating Margin of GBT has declined.
GBT's Gross Margin of 78.03% is amongst the best of the industry. GBT outperforms 90.77% of its industry peers.
GBT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.23%
PM (TTM) 0.96%
GM 78.03%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
GBT.PA Yearly Profit, Operating, Gross MarginsGBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

GBT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for GBT remains at a similar level compared to 1 year ago.
GBT has more shares outstanding than it did 5 years ago.
GBT has a worse debt/assets ratio than last year.
GBT.PA Yearly Shares OutstandingGBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
GBT.PA Yearly Total Debt VS Total AssetsGBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.10 indicates that GBT is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.10, GBT is in line with its industry, outperforming 46.15% of the companies in the same industry.
GBT has a debt to FCF ratio of 8.88. This is a slightly negative value and a sign of low solvency as GBT would need 8.88 years to pay back of all of its debts.
GBT's Debt to FCF ratio of 8.88 is in line compared to the rest of the industry. GBT outperforms 43.08% of its industry peers.
A Debt/Equity ratio of 0.93 indicates that GBT is somewhat dependend on debt financing.
GBT's Debt to Equity ratio of 0.93 is on the low side compared to the rest of the industry. GBT is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.88
Altman-Z 2.1
ROIC/WACC0.46
WACC6.95%
GBT.PA Yearly LT Debt VS Equity VS FCFGBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

GBT has a Current Ratio of 2.32. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.32, GBT is doing good in the industry, outperforming 63.08% of the companies in the same industry.
A Quick Ratio of 1.03 indicates that GBT should not have too much problems paying its short term obligations.
GBT has a Quick ratio of 1.03. This is comparable to the rest of the industry: GBT outperforms 44.62% of its industry peers.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.03
GBT.PA Yearly Current Assets VS Current LiabilitesGBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

The earnings per share for GBT have decreased strongly by -76.89% in the last year.
The earnings per share for GBT have been decreasing by -15.50% on average. This is quite bad
GBT shows a decrease in Revenue. In the last year, the revenue decreased by -2.01%.
The Revenue has been growing slightly by 0.59% on average over the past years.
EPS 1Y (TTM)-76.89%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%

3.2 Future

The Earnings Per Share is expected to decrease by -5.56% on average over the next years.
GBT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.86% yearly.
EPS Next Y-70.82%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue Next Year-3.81%
Revenue Next 2Y-0.32%
Revenue Next 3Y1.12%
Revenue Next 5Y3.86%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GBT.PA Yearly Revenue VS EstimatesGBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
GBT.PA Yearly EPS VS EstimatesGBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 28.79 indicates a quite expensive valuation of GBT.
Compared to the rest of the industry, the Price/Earnings ratio of GBT is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.31. GBT is around the same levels.
Based on the Price/Forward Earnings ratio of 12.02, the valuation of GBT can be described as correct.
86.15% of the companies in the same industry are more expensive than GBT, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.59, GBT is valued rather cheaply.
Industry RankSector Rank
PE 28.79
Fwd PE 12.02
GBT.PA Price Earnings VS Forward Price EarningsGBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GBT is valued cheaply inside the industry as 93.85% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, GBT is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.95
EV/EBITDA 4.31
GBT.PA Per share dataGBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

GBT's earnings are expected to decrease with -10.60% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.69%, GBT has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.16, GBT pays a better dividend. On top of this GBT pays more dividend than 86.15% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, GBT has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

The dividend of GBT decreases each year by -10.05%.
Dividend Growth(5Y)-10.05%
Div Incr Years0
Div Non Decr Years1
GBT.PA Yearly Dividends per shareGBT.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

81.48% of the earnings are spent on dividend by GBT. This is not a sustainable payout ratio.
GBT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP81.48%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
GBT.PA Yearly Income VS Free CF VS DividendGBT.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M
GBT.PA Dividend Payout.GBT.PA Dividend Payout, showing the Payout Ratio.GBT.PA Dividend Payout.PayoutRetained Earnings

GUERBET

EPA:GBT (11/28/2025, 7:00:00 PM)

17.56

-0.46 (-2.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-23 2025-10-23
Earnings (Next)02-04 2026-02-04
Inst Owners15.78%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap221.96M
Revenue(TTM)809.67M
Net Income(TTM)7.74M
Analysts46
Price Target16.58 (-5.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP81.48%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.96%
PT rev (3m)-38.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-60.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-6.14%
Valuation
Industry RankSector Rank
PE 28.79
Fwd PE 12.02
P/S 0.27
P/FCF 4.95
P/OCF 2.37
P/B 0.59
P/tB 0.81
EV/EBITDA 4.31
EPS(TTM)0.61
EY3.47%
EPS(NY)1.46
Fwd EY8.32%
FCF(TTM)3.55
FCFY20.22%
OCF(TTM)7.41
OCFY42.17%
SpS64.06
BVpS29.76
TBVpS21.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.21
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROCE 4.49%
ROIC 3.17%
ROICexc 3.67%
ROICexgc 4.33%
OM 4.23%
PM (TTM) 0.96%
GM 78.03%
FCFM 5.54%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.61%
ROICexc(5y)4.69%
ROICexgc(3y)5.43%
ROICexgc(5y)6.06%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexgc growth 3Y-4.82%
ROICexgc growth 5Y-5.63%
ROICexc growth 3Y2.13%
ROICexc growth 5Y-2.41%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.88
Debt/EBITDA 3.26
Cap/Depr 66.32%
Cap/Sales 6.02%
Interest Coverage 1.61
Cash Conversion 86.9%
Profit Quality 580.05%
Current Ratio 2.32
Quick Ratio 1.03
Altman-Z 2.1
F-Score5
WACC6.95%
ROIC/WACC0.46
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.89%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
EPS Next Y-70.82%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%
Revenue Next Year-3.81%
Revenue Next 2Y-0.32%
Revenue Next 3Y1.12%
Revenue Next 5Y3.86%
EBIT growth 1Y-41.57%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year61.5%
EBIT Next 3Y25.44%
EBIT Next 5Y21.78%
FCF growth 1Y183.49%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y2774.75%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%

GUERBET / GBT.PA FAQ

What is the ChartMill fundamental rating of GUERBET (GBT.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to GBT.PA.


Can you provide the valuation status for GUERBET?

ChartMill assigns a valuation rating of 5 / 10 to GUERBET (GBT.PA). This can be considered as Fairly Valued.


How profitable is GUERBET (GBT.PA) stock?

GUERBET (GBT.PA) has a profitability rating of 3 / 10.


Can you provide the financial health for GBT stock?

The financial health rating of GUERBET (GBT.PA) is 4 / 10.


How sustainable is the dividend of GUERBET (GBT.PA) stock?

The dividend rating of GUERBET (GBT.PA) is 3 / 10 and the dividend payout ratio is 81.48%.